November 2008

Expanded blood testing can reveal much about individuals’ health risks, but how should health plans decide on coverage?

Steven R. Peskin, MD, MBA

Because readings in the clinic are unreliable and are a questionable guide to diagnosing and treating high blood pressure, self-monitoring deserves a look

Lola Butcher

Health plans are evaluating whether to stop carving out drug benefits, disease management, and even behavioral health management

Martin Sipkoff

Once accused of milking the system, oncologists are now complaining that they are losing money on some drugs that they administer

John Carroll

The man credited with health care innovation at IBM warns against any overhaul that would make companies disinclined to participate
Tomorrow’s Medicine
Tetrabenazine inhibits the transport of a molecule called vesicular monoamine transporter type 2 or VMAT2

Thomas Morrow, MD

Medication Management
The increasing use of electronic records may lead the way toward access to diagnostic rationales and long-range patient treatment histories

Martin Sipkoff

Plan Watch
Molina Healthcare of Michigan leans on education in effort to improve care for black men

Frank Diamond

Legislation & Regulation
Though the legislation isn’t comprehensive and won’t be a burden, some health plans will need to scramble to build specialist provider networks

John Carroll